Literature DB >> 8281714

Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.

Y Arimura1, S Minoshima, Y Kamiya, U Tanaka, K Nakabayashi, K Kitamoto, T Nagasawa, T Sasaki, K Suzuki.   

Abstract

Anti-MPO antibodies, serum MPO and cytokines were examined in 106 patients with glomerulonephritis. Twenty-three patients had anti-MPO antibodies and crescent formation; 17 had crescentic glomerulonephritis (CRGN) and the remaining 6 had focal segmental necrosis with less than 50% crescent formation in the observed glomeruli. Pauci-immune CRGN accounted for 28 of 43 CRGN cases. Anti-MPO antibody titers were significantly higher in the cellular crescent stage and their titers correlated well with the number of crescents. Clinical observation revealed that 11 of 18 patients with anti-MPO antibody-associated CRGN had a respiratory tract infection prior to the onset of overt glomerulonephritis. Serum MPO was detected in 20 of 23 patients with anti-MPO antibodies and the amounts of MPO were especially high in the cellular crescent stage and correlated with anti-MPO antibodies. TNF-alpha and IL-6 were also detected in the sera in parallel with the anti-MPO antibody titers. These data suggest that anti-MPO antibodies, TNF-alpha and IL-6, induced by the infection, may activate neutrophils and MPO itself released from neutrophils, may play an important pathogenetic role in glomerular capillary necrosis leading to CRGN.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281714

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  17 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system.

Authors:  Joshua M Astern; William F Pendergraft; Ronald J Falk; J Charles Jennette; Alvin H Schmaier; Fakhri Mahdi; Gloria A Preston
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

3.  The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Alvise Berti; Roscoe Warner; Kent Johnson; Divi Cornec; Darrell R Schroeder; Brian F Kabat; Carol A Langford; Cees G M Kallenberg; Philip Seo; Robert F Spiera; E William St Clair; Fernando C Fervenza; John H Stone; Paul A Monach; Ulrich Specks; Peter A Merkel
Journal:  J Autoimmun       Date:  2019-07-15       Impact factor: 7.094

4.  AP-VAS 2012 case report: a case of ANCA-negative pauci-immune crescentic glomerulonephritis associated with IL-6-producing adenosquamous cell carcinoma of the lung.

Authors:  Takashi Morikawa; Atsuhiro Yoshida; Shinya Kobayashi; Mikiko Shibata; Masahiro Hamada; Masatsugu Kishida; Chizuko Kitabayashi; Haruko Daga; Yoshio Konishi; Koji Takeda; Masahito Imanishi
Journal:  CEN Case Rep       Date:  2013-03-14

5.  Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Authors:  Hua Ye; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

6.  The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.

Authors:  Naro Ohashi; Sayaka Ishigaki; Kazuto Kitajima; Naoko Tsuji; Shinsuke Isobe; Takamasa Iwakura; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Akihiko Kato; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2014-12-21       Impact factor: 2.801

7.  Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.

Authors:  Dennis Huugen; Hong Xiao; Anita van Esch; Ronald J Falk; Carine J Peutz-Kootstra; Wim A Buurman; Jan Willem Cohen Tervaert; J Charles Jennette; Peter Heeringa
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

8.  Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012.

Authors:  Kazuo Suzuki
Journal:  Clin Exp Nephrol       Date:  2013-04-25       Impact factor: 2.801

9.  Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.

Authors:  H Ye; M-H Zhao; Y Gao; X-H Guo; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 10.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.